Savile, Christopher Kenneth

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 8% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -27%
Success rate 73%
Average holding period 220
Transactions 28
Savile, Christopher Kenneth's trades of Willow Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
250.43
Quantity 50,514 -22.9%
Value CA$1,832,487
Transaction date
Purchase
Price
206.41
Quantity 67,365 -9.5%
Value CA$2,644,538
Transaction date
Sale
Price
166.59
Quantity 90,510 +36.2%
Value CA$1,414,584
Transaction date
Purchase
Price
0.14
Quantity 50,000 +8.3%
Value CA$6,750
Transaction date
Purchase
Price
0.12
Quantity 40,000 +7.1%
Value CA$4,900
Transaction date
Purchase
Price
0.16
Quantity 30,000 +6.7%
Value CA$4,650
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-07-18 2024-07-18 B Purchase
50,514 -22.9%
250.43
CA$1,832,487
50,514 -22.9% 250.43 CA$1,832,487
2023-11-30 2023-11-29 B Purchase
67,365 -9.5%
206.41
CA$2,644,538
67,365 -9.5% 206.41 CA$2,644,538
2023-03-31 2023-03-30 S Sale
90,510 +36.2%
166.59
CA$1,414,584
90,510 +36.2% 166.59 CA$1,414,584
2022-11-10 2022-11-10 B Purchase
50,000 +8.3%
0.14
CA$6,750
50,000 +8.3% 0.14 CA$6,750
2022-09-20 2022-09-20 B Purchase
40,000 +7.1%
0.12
CA$4,900
40,000 +7.1% 0.12 CA$4,900
2022-09-13 2022-09-09 B Purchase
30,000 +6.7%
0.16
CA$4,650
30,000 +6.7% 0.16 CA$4,650